Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Daisy REN
    Junior Member
    • Mar 2013
    • 3

    !!Crazy Promotion on EXOME/MHC/RRBS from BGI!!

    Hi all,

    A crazy promotion is coming!! Including Exome/MHC/RRBS, please check all the details through our website
    http://bgiamericas.com/exome_promotion_2013/,
    1. 899USD per sample for 50M/51M 50X Exome projects
    2. 1299USD per sample for for 50M/51M 100X Exome projects,
    including capture kit, library construction, sequencing, and SNP & Indel calling & annotation.

    And http://bgiamericas.com/rrbs_mhc_promotion/,
    MHC
    1. 499USD per sample for MHC capture kit, library construction, 80X mapping depth sequencing, SNP & Indel calling & annotation, and Typing of 26 HLA genes at 4 digit resolution with 95% accuracy.
    RRBS
    2. 999USD per sample for 3G high-quality data,
    3. 1,299USD per sample for 5G high-quality data,
    including library construction, 50bp paired-end sequencing on HiSeq 2000, and standard bioinformatics analysis (alignment, Coverage analysis of promoter and CGI, Methylation analysis of promoter and CGI, DMR analysis).

    They would be valid for the signed contracts in April & May and would be really cost-effective for related researches. If you have any comments, questions or further needs, please contact us through:
    [email protected](US) & [email protected](EU)

    For costumers in London, please contact me directly through [email protected]! I will continually provide full support!

    Yours sincerely,
    Daisy
    Attached Files
    Last edited by Daisy REN; 04-07-2013, 01:06 PM.
  • Daisy REN
    Junior Member
    • Mar 2013
    • 3

    #2
    Huge discount for Exome!
    50%off RRBS!
    499USD for MHC!

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Working...